Skip to content

Clinical trials

Phase 3 Liver Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Diseases Phase: Phase 3 Country / region: Germany Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20101
20111
20121
20141
20191
20201
20211
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Mirum Pharmaceuticals, Inc.2
Abbott1
Gilead Sciences1
Hannover Medical School1
HepNet Study House, German Liverfoundation1
Imunon1
Inventiva Pharma1
Janssen R&D Ireland1
Vir Biotechnology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Diseases12
Digestive System Diseases8
Fibrosis3
Hepatitis3
Non-alcoholic Fatty Liver Disease3
Adenocarcinoma2
Bile Duct Diseases2
Biliary Tract Diseases2
Carcinoma2
Carcinoma, Hepatocellular2

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.